A 6-month assessment of bimatoprost 0.03% vs timolol maleate 0.5%: hypotensive efficacy, macular thickness and flare in ocular-hypertensive and glaucoma patients

被引：0
|
作者：
E Martin
J M Martinez-de-la-Casa
J Garcia-Feijoo
J Troyano
J M Larrosa
J Garcia-Sanchez
机构：
[1] Hospital Clinico San Carlos,
[2] Hospital Miguel Servet,undefined
来源：
Eye | 2007年 / 21卷
关键词：
cystoid macular edema; uveitis; prostaglandin; optical coherence tomography; laser flare meter;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：164 / 168
页数：4
相关论文
共 14 条
  • [1] A 6-month assessment of bimatoprost 0.03% vs timolol maleate 0.5%:: hypotensive efficacy, macular thickness and flare in ocular-hypertensive and glaucoma patients
    Martin, E.
    Martinez-de-la-Casa, J. M.
    Garcia-Feijoo, J.
    Troyano, J.
    Larrosa, J. M.
    Garcia-Sanchez, J.
    EYE, 2007, 21 (02) : 164 - 168
  • [2] A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients
    Manni, G
    Centofanti, M
    Parravano, M
    Oddone, F
    Bucci, MG
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2004, 242 (09) : 767 - 770
  • [3] A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients
    Gianluca Manni
    Marco Centofanti
    Mariacristina Parravano
    Francesco Oddone
    Massimo G. Bucci
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2004, 242 : 767 - 770
  • [4] Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study
    Ozturk, Faruk
    Ermis, Sitki Samet
    Inan, Umit Ubeyt
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2007, 85 (01): : 80 - 83
  • [5] Comparative safety and ocular hypotensive efficacy of brimonidine tartrate 0.2% and timolol maleate 0.5% in patients with glaucoma or ocular hypertension: 12-month results from an ongoing study
    Lewis, RA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 1149 - 1149
  • [6] Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
    Xinghuai Sun
    Ke Yao
    Qinghuai Liu
    Hong Zhang
    Xiaoli Xing
    Aiwu Fang
    Xuanchu Duan
    Minbin Yu
    Michelle Y. Chen
    Jingyuan Yang
    Margot L. Goodkin
    Ophthalmology and Therapy, 2023, 12 : 341 - 353
  • [7] Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
    Sun, Xinghuai
    Yao, Ke
    Liu, Qinghuai
    Zhang, Hong
    Xing, Xiaoli
    Fang, Aiwu
    Duan, Xuanchu
    Yu, Minbin
    Chen, Michelle Y.
    Yang, Jingyuan
    Goodkin, Margot L.
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (01) : 341 - 353
  • [8] Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month efficacy and tolerability, multicenter, open-label prospective study
    Rossi, Gemma Caterina Maria
    Tinelli, Carmine
    Pasinetti, Gian Maria
    Fusetti, Marina
    Pallavicini, Claudio
    Stringa, Massimo
    Vacchi, Sauro
    Stringa, Francesco
    Bianchi, Paolo Emilio
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (05) : 685 - 690
  • [9] The efficacy and safety of unoprostone isopropyl 0.15%, timolol maleate 0.5%, and betaxolol hydrochloride 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Month 12 data.
    Melamed, S
    Nordmann, J
    Yannoulis, N
    Mertz, B
    Schwenninger, C
    Kapik, B
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S556 - S556
  • [10] Switching from concomitant latanoprost 0.005% and timolol 0.5% to a fixed combination of travoprost 0.004%/timolol 0.5% in patients with primary open-angle glaucoma and ocular hypertension: a 6-month, multicenter, cohort study
    Rossi, Gemma C. M.
    Pasinetti, Gian Maria
    Bracchino, Maurizio
    Bucarelli, Massimo
    Franchin, Stefano
    Cerqueti, Piera
    Bellini, Rosa
    Caravati, Cleofe
    Celesia, Laura
    Clemente, Antonella
    Tinelli, Carmine
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (11) : 1705 - 1711
12